Figure 2.

Dose-normalized DHA exposure (AUC(0,∞)/dose) at day 0 and day 1 vs. DHA exposure at day 6 after repeated oral administration of artesunate (4 mg kg⁻¹ day⁻¹) in pregnant women with malaria (A) and in the same women post partum in a healthy state (B)